CAS number: 52-21-1

General information about the Prednisolone Acetate active pharmaceutical ingredient

Prednisolone Acetate as active pharmaceutical ingredient (API) is a corticosteroid or steroid, class of glucocorticoid, used as anti-inflammatory or immunosuppressive agent allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, specific infectious diseases or conditions and organ transplantation. Prednisolone Acetate API works by reducing the itching, redness, scaling, inflammation, and discomfort of various conditions. Prednisolone Acetate comes as oral suspension, ophthalmic solution, ophthalmic suspension and injectable. Prednisolone Acetate is also available as a medicine combined with antibiotics.

Axplora manufactures Prednisolone Acetate API

Prednisolone Acetate API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Prednisolone Acetate API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Prednisolone Acetate API is commercially available in a standard grade specifically designed around various formulation requirements. Prednisolone Acetate API is also available as sterile product (hyperlink for Prednisolone sterile). Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Prednisolone Acetate API.
  • Therapeutic area Dermatologic
  • Monograph PH.EUR.
  • Available grade Standard
  • Regulatory documentation CEP
  • Produced in GRO